Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease

There is an urgent need to identify biomarkers for Alzheimer’s disease (AD), but the identification of reliable blood-based biomarkers has proven to be much more difficult than initially expected. The current availability of high-throughput multi-omics data opens new possibilities in this titanic ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Madrid, Laura, Labrador, Sandra C., González-Pérez, Antonio, Sáez, María E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700271/
https://www.ncbi.nlm.nih.gov/pubmed/34943540
http://dx.doi.org/10.3390/diagnostics11122303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700271/
https://www.ncbi.nlm.nih.gov/pubmed/34943540
http://dx.doi.org/10.3390/diagnostics11122303

Ejemplares similares